Everything you need to make the right decisions
Providing the most comprehensive and up-to-date information and analysis of the Gastrointestinal Remedies market, its consumers and the major players who make up that market.
Point of sale market data
In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on
How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios
What are the different segments within the market and how are those individual segments performing?
What are consumers looking for, what drives their buying habits and what are their main purchase influencers?
From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?
We gather our data from real-world consumers, selected to accurately reflect precise global demographics
What are the key players doing, what has been successful for them and what was their marketing spend?
Using data from our Global New Product Database, what products were launched and how well were they perceived?
What happens next, which areas are likely to experience growth and what opportunities exist within the market?
Expert analysis from a specialist in the field
Written by Jack Duckett, a leading analyst in the Healthcare sector, his extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.
Sales of gastrointestinal remedies have surged in recent years as consumers have become increasingly aware of their diet and digestive health. However, along with a growing awareness of health issues comes a greater desire to treat illness through dietary changes rather than reaching for medications, which is a challenge for the market in years to come. Falling investment in NPD (New Product Development) is also likely to impact consumer engagement, which could in turn lead to a downturn in sales, highlighting the importance of innovation to the category.
Mintel has the answers you’re looking for
What are the key challenges facing the industry and how fast are its rates of growth? Who is the consumer and what do they want? Where are the opportunities, where are the risks and what lies ahead?
This report discusses the following key topics:
Products covered in this Report
This Report analyses the market for all types of indigestion and
stomach remedies available over the counter, which together
constitute the gastrointestinal (GI) remedies market.
The five main categories are as follows:
- Indigestion/heartburn remedies range from simple antacids
such as Rennie or wind relief such as Setlers or Wind-eze to
more potent medication such as Gaviscon or Zantac.
- Laxatives relieve constipation and work in one of several ways,
either by introducing fibre to the bowel, stimulating the bowel or
- Anti-diarrhoeals are usually opiate-based to slow down the
movement of waste through the bowel, and/or contain kaolin to
add bulk to waste and neutralise bacteria. This segment also
includes rehydrating solutions, or electrolyte solutions, which
replace the fluid and salts lost when suffering from diarrhoea.
- Stomach upset remedies, for example, Alka-Seltzer or Andrews,
relieve general nausea and settle the stomach.
- IBS (Irritable Bowel Syndrome) products provide symptomatic
relief for the spasms and bloating which are typical of IBS. Many
of these products, such as Colpermin, are based on peppermint
oil, which is naturally soothing for gastrointestinal problems.
This Report covers only over-the-counter (OTC) (non-prescription)
medication, defined by the Proprietary Association of Great Britain
“Specifically designed to treat the symptoms of common, minor
and self-limiting ailments that do not require a medical diagnosis.”
They are divided into two categories:
P: Pharmacy-only products, which can only be sold through
pharmacies by, or in the presence of, a qualified pharmacist.
GSL: General Sales List, which can be sold in any type of outlet.
Prescription-only Medicines (POMs), which have to be prescribed
by a GP (General Practitioner) and dispensed by a qualified
pharmacist, are not included within the scope of this Report.
What you need to know
The UK gastrointestinal (GI) remedies market enjoyed 3%
growth in value sales in 2015, rising from £281 million in 2014
to £288 million in 2015, driven by strong sales of upset stomach
and irritable bowel syndrome remedies, as well as indigestion
Going forward, however, increased consumer emphasis on
healthy eating could see more people look for dietary solutions
to their GI ailments, lessening demand for targeted remedies. As
such, brands could benefit from product innovation and marketing
to help promote a more holistic approach to health.